Nutra Pharma CEO Rik Deitsch Interviewed by Stockguru.com
CORAL SPRINGS, FL--(Marketwired - Mar 14, 2017) - Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis and HIV that also markets Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) …